1.5 lakh Covid vaccine doses procured from Zydus Cadila: Govt

Published On 2022-12-11 10:30 GMT   |   Update On 2024-02-13 21:21 GMT

New Delhi: A total of 1.5 lakh Covid vaccine doses have been procured by the government from Zydus Cadila at Rs 375.90 per jab (including GST), Minister of State for Health Bharati Pravin Pawar informed the Lok Sabha on Friday.As on December 5, 2022, a total of 102.54 crore first doses and a total of 95.09 crore second doses of COVID-19 vaccine have been administered. A total of 22.29...

Login or Register to read the full article

New Delhi: A total of 1.5 lakh Covid vaccine doses have been procured by the government from Zydus Cadila at Rs 375.90 per jab (including GST), Minister of State for Health Bharati Pravin Pawar informed the Lok Sabha on Friday.

As on December 5, 2022, a total of 102.54 crore first doses and a total of 95.09 crore second doses of COVID-19 vaccine have been administered. A total of 22.29 crore precaution doses have also been administered, Pawar said in a written reply.
She further said that 90 percent of population aged 12 and above in the country have been covered by both doses of COVID-19 vaccine.

Read also: Zydus Lifesciences secures USFDA approval for Estradiol Transdermal System to treat menopause symptoms

Zydus group is headquartered in Ahmedabad, India, and ranks 4th in the Indian pharmaceutical industry. The group has manufacturing sites and research facilities spread across five states of Gujarat, Maharashtra, Goa, Himachal Pradesh, and Sikkim in India and in the US and Brazil.

Zydus' global business has a strong presence in the regulated markets of the US, Europe (France and Spain), and in the high-profile markets of Latin America and South Africa. It is also present in a big way in 25 other emerging markets worldwide.

Read also: USFDA nod to Zydus Lifesciences Migraine drug Topiramate Extended Release




Tags:    
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News